| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Padmaja Tummalapalli, Christopher S Gondi, Dzung H Dinh, Meena Gujrati, Jasti S Ra. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis. International journal of oncology. vol 31. issue 1. 2007-09-14. PMID:17549400. |
rna interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the iomm-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis. |
2007-09-14 |
2023-08-12 |
human |
| Sun Ha Paek, Dong Gyu Kim, Chul-Kee Park, Ji Hoon Phi, Young Yim Kim, Soo Young Im, Jeong Eun Kim, Sung-Hye Park, Hee-Won Jun. The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas. Oncology reports. vol 16. issue 1. 2006-11-09. PMID:16786122. |
the role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas. |
2006-11-09 |
2023-08-12 |
Not clear |
| Sun Ha Paek, Dong Gyu Kim, Chul-Kee Park, Ji Hoon Phi, Young Yim Kim, Soo Young Im, Jeong Eun Kim, Sung-Hye Park, Hee-Won Jun. The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas. Oncology reports. vol 16. issue 1. 2006-11-09. PMID:16786122. |
we studied the expression of matrix metalloproteinases (mmp) and tissue inhibitors of matrix metalloproteinase (timp) in microcystic meningiomas to investigate a possible underlying mechanism for the development of microcysts and of peritumoral edema, which are frequent characteristics of this rare subtype. |
2006-11-09 |
2023-08-12 |
Not clear |
| Ali Fuat Okuducu, Ulrich Zils, Silke A M Michaelis, Christian Mawrin, Andreas von Deimlin. Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9. Cancer. vol 107. issue 6. 2006-10-19. PMID:16894529. |
increased expression of avian erythroblastosis virus e26 oncogene homolog 1 in world health organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and mmp-9. |
2006-10-19 |
2023-08-12 |
Not clear |
| A F Okuducu, U Zils, S A M Michaelis, S Michaelides, A von Deimlin. Ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. Histopathology. vol 48. issue 7. 2006-07-18. PMID:16722933. |
ets-1 is up-regulated together with its target gene products matrix metalloproteinase-2 and matrix metalloproteinase-9 in atypical and anaplastic meningiomas. |
2006-07-18 |
2023-08-12 |
human |
| Kazuto Yamazaki, Brian Eyde. An ultrastructural and immunohistochemical study of microcystic meningioma with emphasis on matrix proteins and connexin 26 type gap junctions. Ultrastructural pathology. vol 28. issue 4. 2005-03-23. PMID:15693636. |
an ultrastructural and immunohistochemical study of microcystic meningioma with emphasis on matrix proteins and connexin 26 type gap junctions. |
2005-03-23 |
2023-08-12 |
Not clear |
| Jorge Llacer, Nzhde Agazaryan, Timothy D Solberg, Claus Promberge. Degeneracy, frequency response and filtering in IMRT optimization. Physics in medicine and biology. vol 49. issue 13. 2005-01-12. PMID:15285252. |
one simple phantom is used to show the development of the analysis tools used and two clinical cases of medium and large dose matrix size (a meningioma and a prostate) are studied in detail. |
2005-01-12 |
2023-08-12 |
Not clear |
| Je-young Yeon, Jung-Il Lee, Jong-Hyun Kim, Yeon-Lim Su. Chordoid meningioma: a case report. Journal of Korean medical science. vol 18. issue 5. 2004-06-09. PMID:14555838. |
histopathologic findings of resected tumor were compatible with chordoid meningioma which included trabeculae of eosinophilic, vacuolated cells in a myxoid matrix with prominent lymphoplasmacellular infiltration. |
2004-06-09 |
2023-08-12 |
Not clear |
| Masaki Okada, Keisuke Miyake, Yoshihito Matsumoto, Nobuyuki Kawai, Katsuzo Kunishio, Seigo Naga. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. Journal of neuro-oncology. vol 66. issue 1-2. 2004-04-01. PMID:15015767. |
matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas. |
2004-04-01 |
2023-08-12 |
Not clear |
| Asha Das, Wan-Loo Tan, Duncan R Smit. Expression of extracellular matrix markers in benign meningiomas. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 23. issue 4. 2004-03-12. PMID:14719542. |
expression of extracellular matrix markers in benign meningiomas. |
2004-03-12 |
2023-08-12 |
Not clear |
| Asha Das, Wan-Loo Tan, Duncan R Smit. Expression of extracellular matrix markers in benign meningiomas. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 23. issue 4. 2004-03-12. PMID:14719542. |
to further characterize their mesenchymal properties, particularly the role of factors requiring adhesion, extracellular matrix degradation, and migration, meningiomas were examined for a panel of extracellular matrix markers. |
2004-03-12 |
2023-08-12 |
Not clear |
| Khawar Siddique, Niranjan Yanamandra, Meena Gujrati, Dzung Dinh, Jasti S Rao, William Oliver. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas. International journal of oncology. vol 22. issue 2. 2003-08-26. PMID:12527924. |
expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas. |
2003-08-26 |
2023-08-12 |
human |
| Sun Ha Paek, Chae-Yong Kim, Young Yim Kim, In Ae Park, Min Seok Kim, Dong Gyu Kim, Hee-Won Jun. Correlation of clinical and biological parameters with peritumoral edema in meningioma. Journal of neuro-oncology. vol 60. issue 3. 2003-03-27. PMID:12510775. |
to examine possible correlations with pte, the authors investigated the clinical parameters and the expressions of vascular endothelial growth factor (vegf), matrix metalloproteinases (mmps), and their inhibitors (timps) in 20 meningiomas. |
2003-03-27 |
2023-08-12 |
Not clear |
| A N Konovalov, U B Makhmudov, A A Grigorian, V N Shimanskiĭ, S V Taniashin, N V Arutiunov, D V Sidorki. [Surgical treatment of meningiomas of the craniovertebral junction]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko. issue 2. 2002-11-18. PMID:12214502. |
surgical techniques to remove meningiomas having a matrix of varying areas were concretized, this is also done in relation to the consistency of a tumor. |
2002-11-18 |
2023-08-12 |
Not clear |
| A C Nordqvist, H Smurawa, T Mathiese. Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. Journal of neurosurgery. vol 95. issue 5. 2001-12-04. PMID:11702875. |
expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. |
2001-12-04 |
2023-08-12 |
Not clear |
| A C Nordqvist, H Smurawa, T Mathiese. Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema. Journal of neurosurgery. vol 95. issue 5. 2001-12-04. PMID:11702875. |
this study was undertaken to analyze the expression of matrix metalloproteinases 2 and 9 (mmp-2 and mmp-9, respectively) in meningiomas associated with different degrees of brain invasion and edema. |
2001-12-04 |
2023-08-12 |
Not clear |
| E Kirches, J Grunewald, P von Bossanyi, R Szibor, I Plate, S Krüger, M Warich-Kirches, K Dietzman. Expression of matrix metalloproteinases in a series of 12 meningiomas. Clinical neuropathology. vol 20. issue 1. 2001-05-03. PMID:11220692. |
expression of matrix metalloproteinases in a series of 12 meningiomas. |
2001-05-03 |
2023-08-12 |
Not clear |
| E Kirches, J Grunewald, P von Bossanyi, R Szibor, I Plate, S Krüger, M Warich-Kirches, K Dietzman. Expression of matrix metalloproteinases in a series of 12 meningiomas. Clinical neuropathology. vol 20. issue 1. 2001-05-03. PMID:11220692. |
therefore, other mechanisms must be responsible for extracellular matrix degradation at least in a fraction of meningiomas. |
2001-05-03 |
2023-08-12 |
Not clear |
| J H Hur, M J Park, I C Park, D H Yi, C H Rhee, S I Hong, S H Le. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression. Journal of Korean medical science. vol 15. issue 3. 2000-11-14. PMID:10895974. |
to evaluate possible roles of matrix metalloproteinase (mmp)-1, -2, tissue inhibitor of metalloproteinase (timp)-1, -2 and membrane-type-1 matrix metalloproteinase (mt1-mmp) in invasion of human gliomas, expressions of these proteins were investigated in ten cases of human glioma and two meningioma tissues and eight human glioma cell lines. |
2000-11-14 |
2023-08-12 |
human |
| Z Kachra, E Beaulieu, L Delbecchi, N Mousseau, F Berthelet, R Moumdjian, R Del Maestro, R Bélivea. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clinical & experimental metastasis. vol 17. issue 7. 2000-06-27. PMID:10845554. |
sixty human brain tumors, classified according to the new world health organization (who) classification including, grade i schwannomas, meningiomas and pilocytic astrocytomas, grade ii astrocytomas, grade iii anaplastic astrocytomas, grade iv glioblastomas, grade iii anaplastic oligodendrogliomas and grade iv glioblastomas and lung and melanoma metastases were analyzed for the expression of three matrix metalloproteinases (mmps), two tissue inhibitors of mmps (timps) and for mmp activity. |
2000-06-27 |
2023-08-12 |
human |